161 related articles for article (PubMed ID: 26345746)
1. MTHFR A1298C polymorphism and ovarian cancer risk: a meta-analysis.
Shi XY; Shen Q
Genet Mol Res; 2015 Jul; 14(3):8211-8. PubMed ID: 26345746
[TBL] [Abstract][Full Text] [Related]
2. Methylenetetrahydrofolate reductase A1298C polymorphism and diabetes risk: evidence from a meta-analysis.
Yan Y; Liang H; Yang S; Wang J; Xie L; Qin X; Li S
Ren Fail; 2014 Aug; 36(7):1013-7. PubMed ID: 24828322
[TBL] [Abstract][Full Text] [Related]
3. Significant association between the MTHFR A1298C polymorphism and hepatocellular carcinoma risk: a meta-analysis.
Chang W; Meng Q; Liu JH; Wu LX; Chen Y; Chen SD
Genet Mol Res; 2015 Dec; 14(4):15972-80. PubMed ID: 26662389
[TBL] [Abstract][Full Text] [Related]
4. ASSOCIATION OF MTHFR A1298C POLYMORPHISM WITH BREAST CANCER AND/OR OVARIAN CANCER RISK: AN UPDATED META-ANALYSIS.
Liu W; Li Y; Li R; Han X; Ma Y; Liu B; Kong X
Afr J Tradit Complement Altern Med; 2016; 13(5):72-86. PubMed ID: 28487897
[TBL] [Abstract][Full Text] [Related]
5. A meta-analysis of the relationship between MTHFR gene A1298C polymorphism and the risk of adult stroke.
Zhang MJ; Hu ZC; Yin YW; Li BH; Liu Y; Liao SQ; Gao CY; Li JC; Zhang LL
Cerebrovasc Dis; 2014; 38(6):425-32. PubMed ID: 25472665
[TBL] [Abstract][Full Text] [Related]
6. Methylenetetrahydrofolate reductase gene polymorphisms in the risk of polycystic ovary syndrome and ovarian cancer.
Xiong Y; Bian C; Lin X; Wang X; Xu K; Zhao X
Biosci Rep; 2020 Jul; 40(7):. PubMed ID: 32639550
[TBL] [Abstract][Full Text] [Related]
7. Association between maternal, fetal and paternal MTHFR gene C677T and A1298C polymorphisms and risk of recurrent pregnancy loss: a comprehensive evaluation.
Yang Y; Luo Y; Yuan J; Tang Y; Xiong L; Xu M; Rao X; Liu H
Arch Gynecol Obstet; 2016 Jun; 293(6):1197-211. PubMed ID: 26530235
[TBL] [Abstract][Full Text] [Related]
8. Methylenetetrahydrofolate reductase A1298C genetic variant& risk of schizophrenia: A meta-analysis.
Rai V; Yadav U; Kumar P; Yadav SK; Gupta S
Indian J Med Res; 2017 Apr; 145(4):437-447. PubMed ID: 28862175
[TBL] [Abstract][Full Text] [Related]
9. Lack of association between methylenetetrahydrofolate reductase gene A1298C polymorphism and breast cancer susceptibility.
Qiu LX; Zhang J; Li WH; Zhang QL; Yu H; Wang BY; Wang LP; Wang JL; Wang HJ; Liu XJ; Luo ZG; Wu XH
Mol Biol Rep; 2011 Apr; 38(4):2295-9. PubMed ID: 21052845
[TBL] [Abstract][Full Text] [Related]
10. No association between MTHFR A1298C gene polymorphism and head and neck cancer risk: a meta-analysis based on 9,952 subjects.
Niu YM; Shen M; Li H; Ni XB; Zhou J; Zeng XT; Leng WD; Wu MY
Asian Pac J Cancer Prev; 2012; 13(8):3943-7. PubMed ID: 23098497
[TBL] [Abstract][Full Text] [Related]
11. Quantitative assessment of the effect of MTHFR polymorphisms on the risk of lung carcinoma.
Zhang Y; Chen GQ; Ji Y; Huang B; Shen WS; Deng LC; Xi L; Cao XM
Mol Biol Rep; 2012 May; 39(5):6203-11. PubMed ID: 22215214
[TBL] [Abstract][Full Text] [Related]
12. Methylenetetrahydrofolate reductase (MTHFR) polymorphisms and susceptibility for cervical lesions: a meta-analysis.
Long S; Yang X; Liu X; Yang P
PLoS One; 2012; 7(12):e52381. PubMed ID: 23285018
[TBL] [Abstract][Full Text] [Related]
13. Lack of association between MTHFR A1298C variant and Alzheimer's disease: evidence from a systematic review and cumulative meta-analysis.
Liu S; Wu Y; Liu X; Zhou J; Wang Z; He Z; Huang Z
Neurol Res; 2017 May; 39(5):426-434. PubMed ID: 28281392
[TBL] [Abstract][Full Text] [Related]
14. Relationship between methylenetetrahydrofolate reductase (MTHFR) gene (A1298C) polymorphism with the risk of stroke: A systematic review and meta-analysis.
Kumar A; Sharma R; Misra S; Nath M; Kumar P
Neurol Res; 2020 Nov; 42(11):913-922. PubMed ID: 32727306
[TBL] [Abstract][Full Text] [Related]
15. Relationship between methylenetetrahydrofolate reductase (MTHFR) A1298C gene polymorphism and type 2 diabetic nephropathy risk: a meta-analysis.
Zhang J; Xiao Y; Zhang XW; Gao ZQ; Han JH
Ren Fail; 2014 Jul; 36(6):974-8. PubMed ID: 24678913
[TBL] [Abstract][Full Text] [Related]
16. MTHFR gene polymorphisms are not involved in pancreatic cancer risk: a meta-analysis.
Tu YL; Wang SB; Tan XL
Asian Pac J Cancer Prev; 2012; 13(9):4627-30. PubMed ID: 23167392
[TBL] [Abstract][Full Text] [Related]
17. Genetic polymorphism of MTHFR A1298C and esophageal cancer susceptibility: a meta-analysis.
Tan X; Wang YY; Dai L; Liao XQ; Chen MW
Asian Pac J Cancer Prev; 2013; 14(3):1951-5. PubMed ID: 23679298
[TBL] [Abstract][Full Text] [Related]
18. Methylenetetrahydrofolate reductase gene A1298C polymorphism and susceptibility to recurrent pregnancy loss: a meta-analysis.
Rai V
Cell Mol Biol (Noisy-le-grand); 2014 Jun; 60(2):27-34. PubMed ID: 24970119
[TBL] [Abstract][Full Text] [Related]
19. MTHFR C677T polymorphism and ovarian cancer risk: a meta-analysis.
Ding XP; Feng L; Ma L
Asian Pac J Cancer Prev; 2012; 13(8):3937-42. PubMed ID: 23098496
[TBL] [Abstract][Full Text] [Related]
20. Associations between Methylenetetrahydrofolate Reductase (MTHFR) Polymorphisms and Non-Alcoholic Fatty Liver Disease (NAFLD) Risk: A Meta-Analysis.
Sun MY; Zhang L; Shi SL; Lin JN
PLoS One; 2016; 11(4):e0154337. PubMed ID: 27128842
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
